Discovery of ledipasvir (GS-5885): a potent, once-daily oral NS5A inhibitor for the treatment of hepatitis C virus infection.
J Med Chem
; 57(5): 2033-46, 2014 03 13.
Article
in En
| MEDLINE
| ID: mdl-24320933
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Antiviral Agents
/
Benzimidazoles
/
Hepatitis C
/
Viral Nonstructural Proteins
/
Fluorenes
Type of study:
Clinical_trials
Limits:
Animals
/
Humans
/
Male
Language:
En
Journal:
J Med Chem
Journal subject:
QUIMICA
Year:
2014
Type:
Article
Affiliation country:
United States